oleic acid has been researched along with bms 309403 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adam, LP; Bassolino-Klimas, D; Ewing, WR; Harrity, T; Huang, Y; Jacobson, BL; Kish, K; Lavoie, TB; Magnin, DR; Parker, R; Patel, M; Robl, JA; Sheriff, S; Simpkins, L; Stoffel, R; Stouch, TR; Sulsky, R; Taunk, P; Taylor, DS; Zhu, Y | 1 |
Ding, K; Ding, M; Li, K; Nie, T; Song, M; Wu, D; Xu, Y; Zhang, Y; Zhou, Y | 1 |
2 other study(ies) available for oleic acid and bms 309403
Article | Year |
---|---|
Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP).
Topics: Adipocytes; Animals; Azoles; Binding Sites; Biphenyl Compounds; Disease Models, Animal; Epidermis; Fatty Acid-Binding Proteins; Hypoglycemic Agents; Hypolipidemic Agents; Mice; Models, Chemical; Radioligand Assay | 2007 |
The discovery of novel and selective fatty acid binding protein 4 inhibitors by virtual screening and biological evaluation.
Topics: Animals; Carboxylic Acids; Cell Line; Drug Discovery; Fatty Acid Binding Protein 3; Fatty Acid-Binding Proteins; Hydrogen Bonding; Interleukin-6; Ligands; Mice; Molecular Docking Simulation; Molecular Dynamics Simulation; Mutagenesis, Site-Directed; Quinolizidines; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2016 |